Table 2. Characteristics of CRC patients between PHF19 high and low cohort from the Zhongshan cohort.
| Variables | PHF19 protein level | P value | |
|---|---|---|---|
| High (n = 59) | Low (n = 24) | ||
| Age (median, years) | 59.5 | 54.4 | 0.145 |
| Gender | 0.81 | ||
| Male | 32 (54.2) | 12 (50.0) | |
| female | 27 (45.8) | 12 (50.0) | |
| Grade | 0.536 | ||
| High and moderate | 47 (79.7) | 21 (87.5) | |
| Poorly | 12 (20.3) | 3 (12.5) | |
| Stage | 0.041 | ||
| I | 4 (6.8) | 5 (20.8) | |
| II | 18 (30.5) | 11 (45.8) | |
| III | 18 (30.5) | 6 (25.0) | |
| IV | 19 (32.2) | 2 (8.3) | |
| AJCC T stage | 0.77 | ||
| T1-T2 | 12 (20.3) | 6 (25.0) | |
| T3-T4 | 47 (79.7) | 18 (75.0) | |
| AJCC N stage | 0.454 | ||
| N0 | 35 (59.3) | 17 (70.8) | |
| N1-N2 | 24 (40.7) | 7 (29.2) | |
| AJCC M stage | 0.027 | ||
| M0 | 40 (67.8) | 22 (91.7) | |
| M1 | 19 (32.2) | 2 (8.3) | |
| Liver metastasis | 0.049 | ||
| Yes | 17 (28.8) | 2 (8.3) | |
| No | 42 (71.2) | 22 (91.7) | |
| Tumor size | 0.335 | ||
| > 5 | 22 (37.9) | 12 (50.0) | |
| ≤ 5 | 36 (62.1) | 12 (50.0) | |
| CA19-9 | 0.702 | ||
| Positive | 30 (66.7) | 13 (59.1) | |
| Negative | 12 (26.7) | 8 (36.4) | |
| NA | 3 (6.7) | 1 (4.5) | |